Journal of General Virology, Vol 79, 1735-1744, Copyright © 1998 by Society for General Microbiology

ARTICLES

Identification and characterization of a cytotoxic T cell epitope of hepatitis C virus presented by HLA-B*3501 in acute hepatitis

M Ibe, T Sakaguchi, K Tanaka, S Saito, S Yokota, T Tanaka, K Shimotohno, Y Chujoh, Y Shiratori, M Omata, K Miwa and M Takiguchi
Department of Tumour Biology, Institute of Medical Science, University of Tokyo, Japan.

In order to clarify the role of cytotoxic T lymphocytes (CTL) in hepatitis C virus (HCV) infection, an HLA-B35-restricted cytotoxic T cell epitope of HCV was identified using a strategy called reverse immunogenetics. Twenty-eight of 53 HCV peptides carrying two anchor residues were selected as HLA-B*3501 binding peptides. These peptides were used to induce the specific cytotoxic T cells in peripheral blood lymphocytes from a patient with acute hepatitis C. Six HLA-B*3501 binding peptides induced the peptide-specific CTL. One (HPNIEEVAL) of five peptides was confirmed as the epitope by the specific T cell clones. A sequence identical to the epitope was detected in isolates of the virus from the patient and a strong CTL response to this epitope was observed in the acute phase of hepatitis C but not in the recovery phase. The specific CTL for this epitope were not detected in peripheral blood lymphocytes from patients with chronic hepatitis C. Together these results suggest that the CTL specific for this epitope have an important role in the elimination of the virus in the patient.

This article has been cited by other articles:

				A. Y. Kim, G. M. Lauer, K. Ouchi, M. M. Addo, M. Lucas, J. S. z. Wiesch, J. Timm, M. Boczanowski, J. E. Duncan, A. G. Wurcel, et al. The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1 Blood, February 1, 2005; 105(3): 1170 - 1178. [Abstract] [Full Text] [PDF]

				T. Hakamada, K. Funatsuki, H. Morita, T. Ugajin, I. Nakamura, H. Ishiko, Y. Matsuzaki, N. Tanaka, and M. Imawari Identification of novel hepatitis C virus-specific cytotoxic T lymphocyte epitopes by ELISpot assay using peptides with human leukocyte antigen-A*2402-binding motifs J. Gen. Virol., June 1, 2004; 85(6): 1521 - 1531. [Abstract] [Full Text] [PDF]

				C. Rollier, E. Depla, J. A. R. Drexhage, E. J. Verschoor, B. E. Verstrepen, A. Fatmi, C. Brinster, A. Fournillier, J. A. Whelan, M. Whelan, et al. Control of Heterologous Hepatitis C Virus Infection in Chimpanzees Is Associated with the Quality of Vaccine-Induced Peripheral T-Helper Immune Response J. Virol., January 1, 2004; 78(1): 187 - 196. [Abstract] [Full Text] [PDF]

				K. Fukada, Y. Sobao, H. Tomiyama, S. Oka, and M. Takiguchi Functional Expression of the Chemokine Receptor CCR5 on Virus Epitope-Specific Memory and Effector CD8+ T Cells J. Immunol., March 1, 2002; 168(5): 2225 - 2232. [Abstract] [Full Text] [PDF]

				D. K. H. Wong, D. D. Dudley, P. B. Dohrenwend, G. M. Lauer, R. T. Chung, D. L. Thomas, and B. D. Walker Detection of Diverse Hepatitis C Virus (HCV)-Specific Cytotoxic T Lymphocytes in Peripheral Blood of Infected Persons by Screening for Responses to All Translated Proteins of HCV J. Virol., February 1, 2001; 75(3): 1229 - 1235. [Abstract] [Full Text]